<DOC>
	<DOCNO>NCT00670254</DOCNO>
	<brief_summary>Severe sepsis disease high mortality . Development shock serious complication increase risk death considerably . Application low dose hydrocortisone currently recommend patient severe septic shock establish . Hydrocortisone therapy hemodynamic stabilize effect may reverse shock , however , preventive application investigate large study . The study investigate whether low dose hydrocortisone prevents development shock patient severe sepsis . It postulate shock prevention may also affect morbidity mortality .</brief_summary>
	<brief_title>Hydrocortisone Prevention Septic Shock</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Severe sepsis accord ACCP/CCM criterion Onset severe sepsis &lt; 48 hour Informed consent Effective contraception fertile woman Septic shock Known hypersensitivity hydrocortisone additives Glucocorticoid history warrant continuation glucocorticoid administration Other indication systemic glucocorticoid therapy DNRorder Moribund patient Pregnancy Breast feed woman Age &lt; 18 year Other interventional study Relationship investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Sepsis</keyword>
	<keyword>Septic</keyword>
	<keyword>Shock</keyword>
	<keyword>Glucocorticoids</keyword>
	<keyword>Hydrocortisone</keyword>
</DOC>